AVADEL PHARMACEUTICALS (AVDL) Stock Earnings & Estimates
USA - NASDAQ:AVDL - IE00BDGMC594 - Common Stock
14 USD
-0.2 (-1.41%)
13.8 USD
-0.2 (-1.43%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.963M | 169.117M 504.79% | 277.71M 64.21% | 363.25M 30.80% | 441.9M 21.65% | 471.25M 6.64% | 500.46M 6.20% | 523.26M 4.56% | N/A | ||
| EBITDA YoY % growth | -93.723M -10.54% | -136.083M -45.20% | -39.718M 70.81% | 34.578M 187.06% | 123.81M 258.06% | 225.35M 82.01% | 161.88M -28.17% | 185.88M 14.83% | N/A | N/A | |
| EBIT YoY % growth | -95.216M -11.23% | -137.849M -44.78% | -42.399M 69.24% | 27.454M 164.75% | 97.678M 255.79% | 138.82M 42.12% | 158.56M 14.22% | 180.31M 13.72% | 204M 13.14% | 232.56M 14.00% | |
| Operating Margin | N/A | -492.97% | -25.07% | 9.89% | 26.89% | 31.41% | 33.65% | 36.03% | 38.99% | N/A | |
| EPS YoY % growth | -2.25 -70.45% | -2.01 10.67% | -0.52 74.13% | 0.23 144.24% | 0.78 239.40% | 1.21 54.32% | 2.81 133.19% | 2.44 -13.25% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.07 322.90% | 0.10 304.00% | 0.12 339.70% | 0.16 60.65% | 0.18 163.12% | 0.21 105.00% | 0.10 -14.89% | 0.14 -11.11% | 0.19 10.14% | 0.24 17.07% |
| Revenue Q2Q % growth | 75.045M 50.01% | 79.608M 57.92% | 81.58M 55.36% | 90.188M 32.38% | 92.081M 22.70% | 97.181M 22.07% | 83.13M 1.90% | 90.984M 0.88% | 100.37M 9.00% | 107.92M 11.05% |
| EBITDA Q2Q % growth | 13.906M 724.79% | 17.32M 2,911.69% | 14.79M 779.69% | 19.074M 76.99% | 18.462M 32.76% | 21.93M 26.62% | 15.606M 5.52% | 21.114M 10.70% | 28.866M 56.35% | 35.7M 62.79% |
| EBIT Q2Q % growth | 9.155M 2,899.69% | 12.421M 476.74% | 14.824M 593.97% | 19.992M 125.03% | 23.732M 159.22% | 28.424M 128.84% | 14.484M -2.29% | 19.992M | 27.846M 17.34% | 34.68M 22.01% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.10 171.43% | 0.03 | 0.07 | 258.07% |
| Q1 2025 Q2Q % growth | -0.05 83.33% | -0.07 | 0.02 | 31.20% |
| Q4 2024 Q2Q % growth | -0.05 82.76% | -0.04 | -0.01 | -20.15% |
| Q3 2024 Q2Q % growth | -0.03 92.68% | -0.06 | 0.03 | 46.72% |
| Q2 2024 Q2Q % growth | -0.14 83.13% | -0.16 | 0.02 | 11.79% |
| Q1 2024 Q2Q % growth | -0.30 37.50% | -0.21 | -0.09 | -41.55% |
| Q4 2023 Q2Q % growth | -0.29 36.96% | -0.26 | -0.03 | -9.63% |
| Q3 2023 Q2Q % growth | -0.41 -24.24% | -0.38 | -0.03 | -7.98% |
| Q2 2023 Q2Q % growth | -0.83 17.82% | -0.39 | -0.44 | -111.75% |
| Q1 2023 Q2Q % growth | -0.48 -6.67% | -0.38 | -0.10 | -24.86% |
| Q4 2022 Q2Q % growth | -0.46 -21.05% | -0.28 | -0.18 | -66.41% |
| Q3 2022 Q2Q % growth | -0.33 13.16% | -0.26 | -0.07 | -27.71% |
| Q2 2022 Q2Q % growth | -1.01 -206.06% | -0.42 | -0.59 | -141.71% |
| Q1 2022 Q2Q % growth | -0.45 -95.65% | -0.44 | -0.01 | -2.01% |
| Q4 2021 Q2Q % growth | -0.38 -100.00% | -0.42 | 0.04 | 10.01% |
| Q3 2021 Q2Q % growth | -0.38 -90.00% | -0.39 | 0.01 | 3.23% |
| Q2 2021 Q2Q % growth | -0.33 -120.00% | -0.32 | -0.01 | -2.89% |
| Q1 2021 Q2Q % growth | -0.23 -1,050.00% | -0.32 | 0.09 | 29.04% |
| Q4 2020 Q2Q % growth | -0.19 -171.43% | -0.28 | 0.09 | 31.29% |
| Q3 2020 Q2Q % growth | -0.20 16.67% | -0.26 | 0.06 | 21.96% |
| Q2 2020 Q2Q % growth | -0.15 34.78% | -0.10 | -0.05 | -52.79% |
| Q1 2020 Q2Q % growth | -0.02 94.29% | -0.24 | 0.22 | 91.76% |
| Q4 2019 Q2Q % growth | -0.07 | -0.25 | 0.18 | 71.99% |
| Q3 2019 Q2Q % growth | -0.24 | -0.28 | 0.04 | 12.85% |
| Q2 2019 Q2Q % growth | -0.23 | -0.30 | 0.07 | 22.24% |
| Q1 2019 Q2Q % growth | -0.35 | -0.50 | 0.15 | 29.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 68.129M 64.15% | 62.728M | 5.401M | 8.61% |
| Q1 2025 Q2Q % growth | 52.511M 93.21% | 51.724M | 787K | 1.52% |
| Q4 2024 Q2Q % growth | 50.41M 159.14% | 51.034M | -624K | -1.22% |
| Q3 2024 Q2Q % growth | 50.025M 613.22% | 49.579M | 446K | 0.90% |
| Q2 2024 Q2Q % growth | 41.504M 2,674.33% | 38.285M | 3.219M | 8.41% |
| Q1 2024 Q2Q % growth | 27.178M | 26.416M | 762K | 2.88% |
| Q4 2023 Q2Q % growth | 19.453M | 18.574M | 879K | 4.73% |
| Q3 2023 Q2Q % growth | 7.014M | 5.19M | 1.824M | 35.14% |
| Q2 2023 Q2Q % growth | 1.496M | 643.763K | 852.237K | 132.38% |
| Q2 2021 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | -100.00% | % | ||
| Q4 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2020 Q2Q % growth | -100.00% | % | ||
| Q2 2020 Q2Q % growth | 10.091M -42.51% | 7.516M | 2.575M | 34.26% |
| Q1 2020 Q2Q % growth | 12.243M -25.52% | 10.353M | 1.89M | 18.26% |
| Q4 2019 Q2Q % growth | 10.995M | 9.316M | 1.679M | 18.02% |
| Q3 2019 Q2Q % growth | 14.229M | 10.455M | 3.774M | 36.10% |
| Q2 2019 Q2Q % growth | 17.554M | 10.71M | 6.844M | 63.90% |
| Q1 2019 Q2Q % growth | 16.437M | 14.153M | 2.284M | 16.14% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.35% | -36.26% | -4.88% | 18.72% |
| Revenue | -0.05% | 4.19% | 0.27% | 4.67% |